Training, medical supervision, and continuous education are key to ensuring the health of the pediatric population. On World Health Day and Children's Day, health specialists raised alarms about the management of type 1 diabetes (T1D) in children, warning that improper insulin administration techniques can compromise disease control and patients' quality of life. Type 1 diabetes is a chronic autoimmune condition typically diagnosed in early childhood, requiring daily insulin injections to regulate blood glucose levels. A problem beyond diagnosis. According to sector specialists, the challenge isn't just access to treatment, but how it's applied. Mariana Buss, Medical Manager for Latin America at embecta™, explained that the administration technique can directly influence metabolic stability, growth, and physical development in girls, boys, and adolescents. "Proper insulin management not only impacts glycemic control but also quality of life," she noted. Injection technique, the critical point. International clinical guidelines like FITTER highlight that how insulin is injected is a key, though often underestimated, treatment component. Key recommendations include: using 4mm needles in children to avoid intramuscular injections; injecting into skin folds in young children; constantly rotating injection sites (abdomen, arms, thighs, buttocks); avoiding needle reuse to prevent skin damage; proper insulin storage. These practices aim to improve drug absorption and reduce complications like glucose fluctuations or skin alterations. Impact on daily life. Improper insulin management can lead to greater glycemic variability, injection pain, and even long-term effects on patients' development. Specialists also warn that childhood and adolescence are crucial for forming good habits early on, with medical support and continuous education. A growing phenomenon. Specialists' call also responds to the rising visibility of type 1 diabetes in Mexico and the need to strengthen health education in family and medical settings. In this context, experts stress that insulin management in early childhood is not a minor detail but a critical treatment component that can define the disease's progression.
